早发冠心病血运重建策略比较:多中心分析
该多中心回顾性分析纳入2005至2015年7个医疗中心年龄小于60岁、主要冠状动脉分布狭窄70%或以上的患者,比较冠脉搭桥与经皮冠状动脉介入的效果。搭桥组10年生存优于介入组,再次血运重建风险更低,但卒中风险更高,30天死亡率无显著差异。
要点
- 年龄小于60岁多支病变患者,搭桥10年生存优于介入(HR 0.71)。
- 搭桥组卒中风险高于介入组(1.3% vs 0.07%,P<.001)。
- 搭桥组再次血运重建累积发生率低于介入组(SHR 0.34)。
核心结论
- 年龄小于60岁、累及前降支的两支病变或三支病变患者,搭桥与更长生存和更低再次血运重建风险相关。
研究设计与样本
- 多中心回顾性分析,纳入2005至2015年7个医疗中心的心脏血运重建手术。
- 最终队列包括1945例搭桥患者和2938例介入患者,采用逆概率加权平衡组间差异。
主要发现
- 多支病变患者30天死亡率搭桥0.8%、介入0.7%,P=.86,无显著差异。
- 搭桥组卒中1.3%(n=25),介入组0.07%(n=2),P<.001。
- 搭桥10年生存优于介入,风险比0.71(95%CI 0.57-0.88,P=.002)。
- 再次手术搭桥组13.4%(n=270)、介入组36.4%(n=1068),两组第二次手术多为介入。
- 以死亡为竞争风险,10年再次血运重建累积发生率搭桥低于介入,亚分布风险比0.34(95%CI 0.28-0.40,P<.001)。
关键数值与推荐
- 纳入标准:年龄小于60岁,一支或多支主要冠状动脉分布狭窄70%或以上。
- 排除标准:左主干狭窄50%或以上、ST段抬高型心肌梗死、急诊状态、既往血运重建。
临床怎么用
- 对年龄小于60岁、累及前降支的两支病变或三支病变患者,可优先考虑搭桥以改善长期生存并降低再次血运重建风险。
- 决策时需权衡搭桥较高的卒中风险与长期获益。
局限性
- 为多中心回顾性分析,非随机对照,虽用逆概率加权平衡差异,仍可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The goal of this analysis was to examine the comparative effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention among patients aged less than 60 years. METHODS: We performed a multicenter, retrospective analysis of all cardiac revascularization procedures from 2005 to 2015 among 7 medical centers. Inclusion criteria were age less than 60 years and 70% stenosis or greater in 1 or more major coronary artery distribution. Exclusion criteria were left main 50% or greater, ST-elevation myocardial infarction, emergency status, and prior revascularization procedure. After applying inclusion and exclusion criteria, the final study cohort included 1945 patients who underwent cardiac surgery and 2938 patients who underwent percutaneous coronary intervention. The primary end point was all-cause mortality stratified by revascularization strategy. Secondary end points included stroke, repeat revascularization, and 30-day mortality. We used inverse probability weighting to balance differences among the groups. RESULTS: After adjustment, there was no significant difference in 30-day mortality (surgery: 0.8%; percutaneous coronary intervention: 0.7%, P = .86) for patients with multivessel disease. Patients undergoing surgery had a higher risk of stroke (1.3% [n = 25] vs 0.07% [n = 2], P < .001). Overall, surgery was associated with superior 10-year survival compared with percutaneous coronary intervention (hazard ratio, 0.71; 95% confidence interval, 0.57-0.88; P = .002). Repeat procedures occurred in 13.4% (n = 270) of the surgery group and 36.4% (n = 1068) of the percutaneous coronary intervention group, with both groups mostly undergoing percutaneous coronary intervention as their second operation. Accounting for death as a competing risk, at 10 years, surgery resulted in a lower cumulative incidence of repeat revascularization compared with percutaneous coronary intervention (subdistribution hazard ratio, 0.34; 95% confidence interval, 0.28-0.40; P < .001). CONCLUSIONS: Among patients aged less than 60 years with 2-vessel disease that includes the left anterior descending or 3-vessel coronary artery disease, surgery was associated with greater long-term survival and decreased risk of repeat revascularization.
引用
- Robich MP, Leavitt BJ, Ryan TJ, et al. Comparative effectiveness of revascularization strategies for early coronary artery disease: A multicenter analysis. J Thorac Cardiovasc Surg. 2020. PMID: 32684394. doi:10.1016/j.jtcvs.2020.03.164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。